NCLAT: IRP Has Authority to Take Possession of Assets Owned by Corporate Debtor  ||  NCLAT: NCLT Can Direct Forwarding a Copy of its Order to Relevant Statutory Authorities  ||  Delhi HC: Centre to Expedite Process of Accessibility Features in OTT platforms for PwDs  ||  Delhi HC: Once Worker Provides Testimony Under Oath ‘Burden of Proof’ Shifts on Employer  ||  SC: There Cannot be Discrimination in Matter of Payment of Pension to Retired Judges  ||  SC: India is Not a Dharamshala that Can Entertain Foreign Nationals from All Over  ||  SC: Can Quash Domestic Violence Act Complaints Under Section 482 of CrPC  ||  Supreme Court: Can’t Use Statement of One Accused against Another  ||  SC: Inclusion of Name in Draft NRC Cannot Annul Foreigners Tribunal’s Declaration as Non-Citizen  ||  Supreme Court: Minimum Practice of 3 Years Mandatory to Enter Judicial Service    

Search Results for Tag : diabetes

Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



News

Delhi HC Sets Aside Centre's Ban on FDCs for Type-2 Diabetes(18.02.2019)

Delhi High Court has set aside Centre's notifications banning manufacture and sale of fixed drug combinations (FDCs) used for treatment of Type-2 diab.....

Tags : Delhi High Court, FDCs for Type-2 Diabetes



Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin”(14.12.2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporatio.....

Tags : Kolkata Patent Office, Patent , Diabetes Drug Teneligliptin



Notifications & Circulars

Dr. Jitendra Singh releases 'Indian Guidelines for Diabetes Management'(09.05.2018)

The Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances.....

Tags : Guidelines, Diabetes Management, Release



Disclaimer | Copyright 2025 - All Rights Reserved